{"gene":"EWSR1","run_date":"2026-06-09T23:54:43","timeline":{"discoveries":[{"year":1993,"finding":"EWS-FLI1 chimeric protein functions as a transcriptional activator; deletion analysis revealed that the EWS N-terminal domain (NTD-EWS) acts as a modulatory/regulatory domain for the transcriptional activation properties of the C-terminal FLI1 activation domain of EWS-FLI1, not as an autonomous activator.","method":"Transcriptional reporter assays and deletion analysis in cell transfection experiments","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional reporter assays with deletion constructs in a single study, foundational mechanistic result","pmids":["7503813"],"is_preprint":false},{"year":1994,"finding":"EWS-FLI1 protein displays the same DNA-binding specificity and affinity as wild-type FLI1, with the consensus binding site ACCGGAAG/aT/c; the Ets domain is necessary and sufficient for the DNA-binding specificity of the fusion protein.","method":"Epitope-tagged protein binding site selection, truncation mutant DNA-binding assays in vitro","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro DNA-binding assay with truncation mutants, single lab","pmids":["7517940"],"is_preprint":false},{"year":2001,"finding":"EWS and EWS-FLI1 interact with SF1 and U1C, essential components of the splicing machinery; EWS-FLI1 (but not EWS alone) interferes with hnRNP A1-dependent 5'-splice site selection in an E1A in vivo splicing assay, and this splicing-altering activity coincides with transforming activity.","method":"In vivo splicing assay (E1A gene), mutational analysis, protein interaction assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo splicing assay with mutational analysis, single lab, two orthogonal methods","pmids":["11301318"],"is_preprint":false},{"year":2001,"finding":"EWS-FLI1 activates oncogenic pathways independent of its ETS DNA-binding domain (DBD); DBD point mutants and large deletions retain tumor acceleration in NIH 3T3 cells in vivo, while losing DNA binding in vitro, demonstrating DBD-independent oncogenic signaling.","method":"In vivo tumor assay in NIH 3T3 / SCID mice, dominant-negative FLI1 constructs, in vitro DNA-binding assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo tumorigenesis assay combined with in vitro binding assays, single lab","pmids":["11553628"],"is_preprint":false},{"year":2001,"finding":"EWS protein is extensively and asymmetrically dimethylated on arginine residues within its RGG motifs (29 of 30 Arg-Gly sites at least partially methylated); the protein is also present on the cell surface in addition to the nucleus and cytosol.","method":"Cell-surface biotinylation, isoelectric focusing, avidin-agarose extraction, MALDI and nanoelectrospray tandem mass spectrometry of in-gel-digested peptides","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mass spectrometric mapping of modification sites with rigorous biochemical fractionation, comprehensive mapping of 29/30 sites","pmids":["11278906"],"is_preprint":false},{"year":2003,"finding":"EWS protein self-associates through its C-terminal RNA-binding domain in an RNA-dependent manner (sensitive to RNaseA); EWS-FLI1 can also self-associate and interact with FLI1 via its C-terminal FLI1 domain in an RNA-independent manner; the EWS N-terminal domain mediates both homotypic and heterotypic interactions of EWS and EWS-FLI1.","method":"FRET, mammalian two-hybrid assay, GST pull-down, immunoprecipitation, RNaseA sensitivity assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — four orthogonal methods (FRET, MTH, GST pulldown, Co-IP), single lab but comprehensive mechanistic dissection","pmids":["14534527"],"is_preprint":false},{"year":2003,"finding":"Methylation process controls EWS protein expression and subcellular localization: inhibition of methylation with adenosine dialdehyde decreases EWS protein in both the nucleus and cell surface; mitogenic stimulation of normal T cells increases methylated EWS on the cell surface ~10-fold.","method":"Cell-surface biotinylation, immunoblotting after methylation inhibitor treatment, mitogenic stimulation of PBMC","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — pharmacological inhibition and stimulation experiments, single lab, two orthogonal approaches","pmids":["12915128"],"is_preprint":false},{"year":2004,"finding":"EWS-FLI1 purified as recombinant protein from E. coli adopts a largely unfolded conformation under native conditions, yet specifically binds DNA and activates transcription, confirming its intrinsically disordered nature and transcriptional activity.","method":"Recombinant protein purification, circular dichroism, fluorescence spectroscopy, in vitro DNA-binding and transcription assays","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with biophysical characterization and functional assays, single lab","pmids":["15491164"],"is_preprint":false},{"year":2006,"finding":"EWS-FLI1 directly binds RNA helicase A (RHA) at the region spanning amino acids 630–1020 of RHA; endogenous RHA co-immunoprecipitates with EWS-FLI1 in ESFT cell lines; RHA and EWS-FLI1 co-occupy target gene promoters (e.g., Id2) by ChIP; RHA stimulates EWS-FLI1 transcriptional activity and enhances anchorage-independent transformation.","method":"Phage display, GST pull-down, ELISA, reciprocal Co-IP, chromatin immunoprecipitation, luciferase reporter assay, anchorage-independent growth assay","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (phage display, GST pulldown, Co-IP, ChIP, reporter assay, transformation assay), single lab","pmids":["16740692"],"is_preprint":false},{"year":2007,"finding":"EWS is required for completion of B cell development and meiosis in vivo: Ews-null mice show cell-autonomous defects in pre-B lymphocyte development, spermatocyte XY bivalent formation failure, and massive apoptosis during meiosis. Loss of EWS also results in premature senescence of mouse embryonic fibroblasts and hypersensitivity to ionizing radiation. EWS interacts with lamin A/C and its loss reduces lamin A/C expression.","method":"Ews knockout mice generation, lymphocyte analysis, meiosis analysis, MEF senescence assays, ionizing radiation sensitivity assay, co-immunoprecipitation (EWS–lamin A/C interaction), immunoblotting","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with multiple defined phenotypes plus Co-IP for binding partner, comprehensive in vivo study","pmids":["17415412"],"is_preprint":false},{"year":2007,"finding":"EWSR1 maintains mitotic integrity: morpholino knockdown of zebrafish ewsr1a/ewsr1b causes multipolar or abnormal mitotic spindles followed by p53-mediated apoptosis in the CNS; siRNA silencing of EWSR1 in HeLa cells causes mitotic defects and apoptosis, confirming conservation of this function.","method":"Morpholino knockdown in zebrafish, siRNA knockdown in HeLa cells, mitotic spindle imaging","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two model systems with defined spindle phenotype, single lab","pmids":["17912356"],"is_preprint":false},{"year":2007,"finding":"EWS-ATF1 fusion protein, when expressed from the EWS promoter in mice, directly induces FOS expression in an ERK-independent manner; EWS/ATF1 expression is sufficient to transform neural crest-derived cells and produce CCS-like sarcomas in vivo.","method":"Inducible transgenic mouse model, lineage-tracing experiments, siRNA knockdown of FOS, promoter analysis","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic mouse with lineage tracing and direct target (FOS) validation, single lab","pmids":["23281395"],"is_preprint":false},{"year":2009,"finding":"The EWSR1/NR4A3 fusion protein directly activates the PPARG promoter through a specific DNA response element; band-shift experiments confirm EWSR1/NR4A3 binding to this element, and a truncated native NR4A3 isoform can negatively regulate the fusion protein's activity on this promoter.","method":"Expression microarray, western blot/IHC validation, band-shift (EMSA) assays, transient transfection reporter assays, bioinformatic promoter analysis","journal":"The Journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA and reporter assay with mutagenesis-level promoter dissection, single lab","pmids":["18855877"],"is_preprint":false},{"year":2010,"finding":"Endogenous EWS is required for hematopoietic stem cell quiescence; Ews-deficient hematopoietic stem/progenitor cells undergo early senescence with increased p16INK4a and senescence-associated β-galactosidase activity.","method":"Ews knockout mice, flow cytometry of HSPCs, β-galactosidase senescence assay, p16INK4a immunoblotting","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with defined cellular phenotype, single lab","pmids":["21030557"],"is_preprint":false},{"year":2012,"finding":"Acetylation of the C-terminal FLI1 DNA-binding domain of EWS-FLI1 increases its DNA-binding activity in vitro; overexpression of PCAF or treatment with HDAC inhibitors increases EWS-FLI1 transcriptional activity in co-transfection assays.","method":"In vitro acetylation assay, EMSA, luciferase reporter assay, PCAF overexpression, HDAC inhibitor treatment","journal":"Frontiers in oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro acetylation with binding assay and cell-based reporter, single lab; full-length EWS-FLI1 acetylation in ES cells unclear","pmids":["22973553"],"is_preprint":false},{"year":2013,"finding":"EWS regulates expression of Drosha (a miRNA microprocessor): EWS deficiency increases Drosha expression, elevating miR-29b and miR-18b levels, which post-transcriptionally repress Col4a1 and CTGF, contributing to dermal developmental defects. Knockdown of Drosha rescues miRNA-dependent downregulation of these targets.","method":"Ews knockout mouse embryonic fibroblasts, qPCR for miRNA levels, Drosha knockdown rescue experiment, immunoblotting for Col4a1 and CTGF","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with rescue experiment, mechanistic pathway validated by Drosha knockdown, single lab","pmids":["24185621"],"is_preprint":false},{"year":2013,"finding":"Wild-type EWS interacts directly with REST (RE1-Silencing Transcription Factor) by co-immunoprecipitation; genome-wide ChIP shows EWS binds chromatin at/near NRSE (neuron-restrictive silencer element) sites; EWS and REST cooperatively suppress neuronal gene expression and oncogenic transformation in Ewing sarcoma cells.","method":"Co-immunoprecipitation, ChIP-seq, RNA-seq after RNAi, functional transformation assays","journal":"Genes & cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus ChIP-seq and functional KD assays, single lab","pmids":["24069508"],"is_preprint":false},{"year":2014,"finding":"EWS-FLI1 reprograms gene regulatory circuits by two divergent mechanisms: (1) at GGAA repeat elements EWS-FLI1 multimers induce chromatin opening and create de novo enhancers that physically interact with target promoters; (2) at conserved ETS-motif enhancers EWS-FLI1 displaces wild-type ETS factors to inactivate them.","method":"ChIP-seq, ATAC-seq/DNaseI-seq, chromatin conformation capture, EWS-FLI1 knockdown/rescue, luciferase reporter assays","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal epigenomic methods with knockdown/rescue and chromatin looping confirmation, rigorous mechanistic dissection","pmids":["25453903"],"is_preprint":false},{"year":2014,"finding":"EWS-WT1(+KTS) fusion protein directly binds the sequence 5'-GGAGG(A/G)-3' upstream of the LRRC15 gene and transactivates it; this binding site differs from known WT1 consensus sites, demonstrating that the +KTS insertion abrogates canonical WT1 binding but confers a new specificity.","method":"cDNA subtractive hybridization, in vitro and in vivo DNA binding assays, ChIP, mutagenesis of binding element, inducible expression system","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro and in vivo binding with mutagenesis, ChIP, and inducible expression system in a single rigorous study","pmids":["12923058"],"is_preprint":false},{"year":2014,"finding":"EWS-WT1 directly binds the proximal promoter of ASCL1 through multiple WT1-responsive elements and activates ASCL1 transcription, inducing a neural gene expression program and partial neural differentiation in DSRCT cells.","method":"Transgenic mouse model (EWS-WT1 under native Ews promoter), promoter-binding assays, ASCL1 knockdown, inducible expression in primary fibroblasts","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic model with direct promoter binding assay and KD rescue, single lab","pmids":["24934812"],"is_preprint":false},{"year":2014,"finding":"EWS interacts with Aurora B kinase via the R565 residue in its RGG3 domain, and EWS is required for recruiting Aurora B to the midzone during anaphase; loss of EWS or EWS-FLI1 expression causes midzone defects and aneuploidy; ectopic EWS expression rescues midzone defects in Ewing sarcoma cells.","method":"siRNA knockdown, immunofluorescence/live imaging of midzone, co-immunoprecipitation, domain deletion/point mutation analysis, rescue experiments","journal":"Cell cycle","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with domain mutagenesis and functional rescue, single lab","pmids":["25483190"],"is_preprint":false},{"year":2015,"finding":"EWS-FLI1 acts as a splicing regulatory hub: it binds RNA at intron-exon boundaries (CLIP-seq), interacts with spliceosomal proteins DDX5, hnRNP K, and PRPF6, and produces alternative splicing of CLK1, CASP3, PPFIBP1, and TERT isoforms; the small molecule YK-4-279 disrupts EWS-FLI1 interactions with DDX5 and RHA, reversing splicing alterations.","method":"CLIP-seq, exon array, RNA-seq, Co-IP with splicing factors, YK-4-279 inhibitor treatment, telomerase activity assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (CLIP-seq, Co-IP, RNA-seq, pharmacological inhibition with reversal of phenotype), single lab","pmids":["25737553"],"is_preprint":false},{"year":2015,"finding":"EWS-FLI1 inhibits RNA helicase A (RHA) helicase activity in a dose-dependent manner without affecting ATPase activity; EWS-FLI1 has RNA-binding activity and alters the RNA-binding profile of RHA; the (S)-enantiomer of YK-4-279 specifically reverses EWS-FLI1 inhibition of RHA helicase activity.","method":"In vitro helicase activity assay, ATPase assay, RNA-binding assay, separated enantiomer treatment","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic assays with dose-response and enantiomer specificity, single lab","pmids":["25564528"],"is_preprint":false},{"year":2015,"finding":"Loss of EWS leads to rapid proteasomal degradation of PGC-1α via increased FBXW7 E3 ubiquitin ligase expression; EWS inactivation causes significant reduction in mitochondrial abundance and activity in MEFs, brown fat, and skeletal muscle; complementation of EWS restores PGC-1α and mitochondrial abundance; depletion of Fbxw7 in Ews-null cells restores PGC-1α.","method":"Ews knockout mice, ubiquitination assay, proteasome inhibitor rescue, Fbxw7 knockdown rescue, mitochondrial abundance/activity measurement, immunoblotting","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with complementation rescue, ubiquitination assay, FBXW7 KD rescue, and in vivo tissue analyses, multiple orthogonal methods","pmids":["25918410"],"is_preprint":false},{"year":2018,"finding":"EWSR1 suppresses R-loops and promotes homologous recombination in the transcriptional response to DNA damage; in Ewing sarcoma, EWS-FLI1 increases transcription causing R-loop accumulation and replication stress, and impairs BRCA1-mediated homologous recombination by enriching BRCA1 interactions with the elongating transcription machinery.","method":"R-loop immunofluorescence (S9.6 antibody), BRCA1 Co-IP with transcription machinery components, EWSR1 knockdown/rescue, DNA damage assays, replication stress assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal mechanistic assays in a high-profile study, loss-of-function with defined molecular phenotypes, published in Nature","pmids":["29513652"],"is_preprint":false},{"year":2019,"finding":"EWS-FLI1 modulates ARID1A pre-mRNA splicing to preferentially produce the ARID1A-L isoform; ARID1A-L directly interacts with EWS-FLI1 protein; ARID1A-L promotes Ewing sarcoma growth and reciprocally stabilizes EWS-FLI1 protein, forming a feed-forward oncogenic loop.","method":"Co-immunoprecipitation (EWS-FLI1 / ARID1A-L), RNA-seq for isoform analysis, shRNA knockdown, rescue experiments, protein stability assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with splicing and functional data, single lab","pmids":["31392992"],"is_preprint":false},{"year":2021,"finding":"TRIM8 is an E3 ubiquitin ligase that ubiquitinates and degrades EWS-FLI1; TRIM8 knockout leads to increased EWS-FLI1 protein levels that is not tolerated by Ewing sarcoma cells; EWS-FLI1 acts as a neomorphic substrate for TRIM8, defining a selective dependency.","method":"CRISPR-Cas9 screen, ubiquitination assay, TRIM8 KO/rescue, protein level analysis, selective dependency validation across >700 cancer cell lines","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — CRISPR screen plus biochemical ubiquitination assay and mechanistic rescue with cross-cancer-line selectivity validation","pmids":["34329586"],"is_preprint":false},{"year":2021,"finding":"SPOP E3 ubiquitin ligase and OTUD7A deubiquitinase control EWS-FLI1 protein stability: casein kinase 1-mediated phosphorylation of the VTSSS degron in the FLI1 domain enhances SPOP-mediated degradation; OTUD7A deubiquitinates and stabilizes EWS-FLI1; depletion of OTUD7A reduces EWS-FLI1 levels and impedes tumor growth in vitro and in vivo.","method":"siRNA/shRNA depletion, ubiquitination assays, Co-IP, phosphorylation assays, xenograft mouse models, AI-based drug screening","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical assays with in vivo validation, single lab","pmids":["34060252"],"is_preprint":false},{"year":2019,"finding":"USP19 deubiquitinase binds to the N-terminal EWS region of EWS-FLI1 and stabilizes the fusion protein; depletion of USP19 reduces EWS-FLI1 protein levels, decreases cell growth, and delays tumor growth in vivo; stabilization is specific for the fusion protein (not EWSR1 or FLI1 alone).","method":"siRNA screening, Co-IP, ubiquitination assays, stable shRNA depletion, xenograft tumor assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA screen with biochemical follow-up and in vivo validation, single lab","pmids":["30700749"],"is_preprint":false},{"year":2021,"finding":"EWS-FLI1 is incorporated into a protein granule/assembly in cells via its low-complexity (LC) domain; the LC domain is required for EWS-FLI1 to form these assemblies and interact with its broad network of protein partners including RNA Pol II; EWSR1 knockdown affects a larger than expected set of transcripts, including many EWS-FLI1-regulated genes.","method":"Cross-linking-based protein assembly assay, siRNA-mediated knockdown, RNA-seq, domain deletion analysis","journal":"RNA","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cross-linking assembly assay with domain deletion and transcriptomic validation, single lab","pmids":["34035145"],"is_preprint":false},{"year":2022,"finding":"EWSR1-ATF1 displays distinct DNA binding that requires the EWSR1 domain and promotes ATF1 retargeting to new distal chromatin sites, activating a 3D connectivity network controlling oncogenic and differentiation programs in Clear Cell Sarcoma; EWSR1-ATF1 depletion reconfigures 3D connectivity and promotes neural crest developmental programs.","method":"ChIP-seq, Hi-C/3D chromatin conformation capture, ATAC-seq, EWSR1-ATF1 depletion, CUT&RUN","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple epigenomic methods with depletion experiments, single lab","pmids":["35477713"],"is_preprint":false},{"year":2023,"finding":"EWSR1 maintains centromere identity by interacting with CENP-A through its SYGQ2 prion-like domain region; EWSR1 binds R-loops through its RNA-recognition motif in vitro; both the SYGQ2 domain and RNA-recognition motif are required for EWSR1 to maintain CENP-A at the centromere in interphase cells.","method":"Co-immunoprecipitation (CENP-A–EWSR1), CENP-A ChIP after EWSR1 depletion, in vitro R-loop binding assay, domain deletion/mutation analysis, immunofluorescence","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with domain mutants and functional CENP-A ChIP, single lab, in vitro R-loop binding assay","pmids":["37243594"],"is_preprint":false},{"year":2024,"finding":"The intrinsically disordered low-complexity domain of EWS (EWSLCD) undergoes phase separation/condensate formation driven by tyrosine residues; higher density and proximity of tyrosines amplify condensate formation; MD simulations revealed tyrosine-rich termini adopt compact conformations with unique intramolecular and intermolecular contact networks.","method":"Paramagnetic relaxation enhancement NMR, microscopy (phase separation), all-atom molecular dynamics simulations, mutational analysis of tyrosine residues","journal":"Journal of the American Chemical Society","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — NMR, MD simulations, and microscopy with mutational analysis, single lab, rigorous biophysical study","pmids":["38492239"],"is_preprint":false}],"current_model":"EWSR1 encodes a multifunctional RNA/DNA-binding protein whose N-terminal low-complexity/prion-like domain (which undergoes phase separation driven by tyrosine residues) serves as a potent transcriptional activation domain when fused to ETS or other transcription factor DNA-binding domains in oncogenic translocations; wild-type EWSR1 regulates transcription (binding RNA Pol II and chromatin), pre-mRNA splicing (interacting with SF1, U1C, DDX5, hnRNP K, PRPF6), suppresses DNA damage-induced R-loops to promote homologous recombination, maintains centromere identity by binding CENP-A via its SYGQ2 domain and centromeric R-loops via its RNA-recognition motif, recruits Aurora B kinase to the midzone through its RGG3 domain to enable cytokinesis, controls PGC-1α protein stability (via FBXW7 ubiquitin ligase) to maintain mitochondrial homeostasis, regulates miRNA biogenesis by modulating Drosha expression, interacts with lamin A/C to support nuclear architecture and senescence suppression, and is essential for B-cell development and meiosis in vivo; EWSR1 protein stability is regulated by the E3 ligases TRIM8 and SPOP (enhanced by CK1 phosphorylation of a degron) and countered by the deubiquitinases OTUD7A and USP19, while arginine methylation controls its subcellular localization and cell-surface exposure."},"narrative":{"mechanistic_narrative":"EWSR1 is a multifunctional RNA/DNA-binding protein whose N-terminal low-complexity, prion-like domain undergoes tyrosine-driven phase separation and mediates homo- and heterotypic protein assemblies, while its C-terminal RNA-binding region directs RNA-dependent self-association [PMID:14534527, PMID:38492239]. In its wild-type role, EWSR1 supports genome integrity and mitotic fidelity: it suppresses DNA damage-induced R-loops to promote BRCA1-mediated homologous recombination [PMID:29513652], maintains centromere identity by binding CENP-A through its SYGQ2 prion-like region and centromeric R-loops via its RNA-recognition motif [PMID:37243594], and recruits Aurora B to the anaphase midzone through the R565 residue of its RGG3 domain to enable faithful division [PMID:25483190], consistent with the spindle and apoptotic defects seen upon its loss [PMID:17912356]. EWSR1 acts in transcription and pre-mRNA splicing, cooperating with REST to repress neuronal genes [PMID:24069508] and controls miRNA biogenesis by modulating Drosha to govern target genes during development [PMID:24185621]. It also sustains mitochondrial homeostasis by protecting PGC-1α from FBXW7-dependent proteasomal degradation [PMID:25918410], interacts with lamin A/C, and is required in vivo for B-cell development, meiosis, and suppression of premature senescence [PMID:17415412, PMID:21030557]. The protein is heavily asymmetrically dimethylated on arginines within its RGG motifs, a modification controlling its abundance, nuclear/cell-surface localization [PMID:11278906, PMID:12915128]. EWSR1 is recurrently the 5' partner in oncogenic fusions (EWS-FLI1, EWS-ATF1, EWSR1-NR4A3, EWS-WT1) where its intrinsically disordered N-terminal domain functions as a phase-separating transactivation module appended to a heterologous DNA-binding domain, reprogramming chromatin and 3D genome architecture and corrupting splicing [PMID:15491164, PMID:25453903, PMID:12923058, PMID:34035145, PMID:35477713].","teleology":[{"year":1994,"claim":"Established that in the EWS-FLI1 fusion the heterologous ETS domain, not the EWS portion, dictates sequence-specific DNA binding, localizing the contribution of EWS to transactivation rather than recognition.","evidence":"in vitro binding-site selection and truncation DNA-binding assays with epitope-tagged protein","pmids":["7517940"],"confidence":"Medium","gaps":["Did not address the function of wild-type EWSR1","Did not test fusion activity in chromatin context"]},{"year":1993,"claim":"Defined the EWS N-terminal domain as a transcriptional regulatory module that modulates the activity of the fused FLI1 domain, framing the fusion as a chimeric transcription factor.","evidence":"transcriptional reporter assays with deletion constructs in transfected cells","pmids":["7503813"],"confidence":"Medium","gaps":["Mechanism of activation not biochemically defined","Wild-type EWSR1 transcriptional role not addressed"]},{"year":2001,"claim":"Connected EWSR1 to the splicing machinery and showed the fusion perturbs splice-site selection, opening a non-transcriptional axis of EWSR1 function.","evidence":"in vivo E1A splicing assay, mutational analysis and interaction assays with SF1/U1C","pmids":["11301318"],"confidence":"Medium","gaps":["Direct RNA targets in vivo not mapped","Splicing role of wild-type EWSR1 incompletely resolved"]},{"year":2001,"claim":"Mapped extensive asymmetric arginine dimethylation across the RGG motifs and detected EWS at the cell surface, establishing a post-translational code and unexpected localization.","evidence":"cell-surface biotinylation, isoelectric focusing and tandem mass spectrometry site mapping","pmids":["11278906"],"confidence":"High","gaps":["Responsible methyltransferase not identified","Functional consequence of each methylation site untested"]},{"year":2003,"claim":"Showed EWSR1 self-associates in an RNA-dependent manner via its C-terminal RNA-binding domain while the N-terminal domain mediates homo/heterotypic interactions, defining the basis for its higher-order assembly.","evidence":"FRET, mammalian two-hybrid, GST pull-down, Co-IP with RNaseA sensitivity","pmids":["14534527"],"confidence":"High","gaps":["Stoichiometry of assemblies not determined","Link to phase separation not yet drawn"]},{"year":2003,"claim":"Demonstrated that arginine methylation controls EWS abundance and partitioning between nucleus and cell surface, with mitogenic signals tuning surface exposure.","evidence":"methylation-inhibitor treatment, cell-surface biotinylation, mitogenic stimulation of T cells","pmids":["12915128"],"confidence":"Medium","gaps":["Pharmacological inhibition is not site-specific","Mechanism linking methylation to localization unresolved"]},{"year":2004,"claim":"Established that the fusion protein is intrinsically disordered yet retains DNA binding and transcriptional activity, anchoring the concept that EWSR1's disordered domain is functionally active without folding.","evidence":"recombinant protein purification, circular dichroism, fluorescence spectroscopy, in vitro DNA-binding/transcription assays","pmids":["15491164"],"confidence":"Medium","gaps":["Behavior of full-length protein in cells not addressed","Condensate behavior not yet examined"]},{"year":2006,"claim":"Identified RNA helicase A as a direct cofactor that co-occupies fusion target promoters and amplifies oncogenic transcription and transformation.","evidence":"phage display, GST pull-down, ELISA, reciprocal Co-IP, ChIP, reporter and anchorage-independent growth assays","pmids":["16740692"],"confidence":"High","gaps":["Whether wild-type EWSR1 uses the same interaction surface untested","Genome-wide co-occupancy not mapped"]},{"year":2007,"claim":"Defined essential in vivo roles for EWSR1 in B-cell development, meiosis, and senescence suppression and identified lamin A/C as a partner, establishing physiological functions beyond cancer.","evidence":"Ews knockout mice, lymphocyte/meiosis analysis, MEF senescence and irradiation assays, Co-IP","pmids":["17415412"],"confidence":"High","gaps":["Molecular basis of meiotic and DNA-damage phenotypes not resolved","Direct vs indirect lamin A/C effects unclear"]},{"year":2007,"claim":"Showed EWSR1 is required for mitotic spindle integrity across zebrafish and human cells, linking its loss to chromosomal instability and apoptosis.","evidence":"morpholino knockdown in zebrafish, siRNA in HeLa, mitotic spindle imaging","pmids":["17912356"],"confidence":"Medium","gaps":["Molecular mechanism at the spindle not defined here","Knockdown specificity not exhaustively controlled"]},{"year":2010,"claim":"Established EWSR1 as a regulator of hematopoietic stem cell quiescence whose loss triggers p16-driven senescence.","evidence":"Ews knockout mice, HSPC flow cytometry, β-galactosidase and p16INK4a assays","pmids":["21030557"],"confidence":"Medium","gaps":["Direct molecular targets in HSCs not identified","Relationship to senescence pathways in other tissues unclear"]},{"year":2013,"claim":"Showed EWSR1 controls miRNA biogenesis by restraining Drosha, defining a post-transcriptional output that shapes developmental gene expression.","evidence":"Ews-null MEFs, miRNA qPCR, Drosha knockdown rescue, target immunoblotting","pmids":["24185621"],"confidence":"Medium","gaps":["Mechanism of Drosha regulation not resolved","Direct vs indirect control of Drosha expression unclear"]},{"year":2013,"claim":"Identified a wild-type EWSR1–REST complex on chromatin that cooperatively silences neuronal genes and restrains transformation.","evidence":"Co-IP, ChIP-seq, RNA-seq after RNAi, transformation assays","pmids":["24069508"],"confidence":"Medium","gaps":["Direct DNA-binding role of EWSR1 within the complex unclear","Single-lab ChIP-seq, no reciprocal validation"]},{"year":2014,"claim":"Resolved two divergent gene-regulatory mechanisms of EWS-FLI1 — de novo enhancer creation at GGAA microsatellites and inactivation of native ETS enhancers — explaining its dual activation/repression output.","evidence":"ChIP-seq, ATAC/DNaseI-seq, chromatin conformation capture, knockdown/rescue, reporter assays","pmids":["25453903"],"confidence":"High","gaps":["Role of EWS phase separation in enhancer formation not addressed here","Wild-type EWSR1 enhancer behavior not compared"]},{"year":2014,"claim":"Demonstrated that EWSR1 fusions to other DNA-binding partners (WT1, ATF1) generate novel binding specificities and target programs, generalizing the chimeric-transactivator model across sarcomas.","evidence":"in vitro/in vivo binding assays, ChIP, mutagenesis, transgenic and inducible expression models","pmids":["12923058","24934812","23281395"],"confidence":"High","gaps":["How the EWS domain alters partner specificity mechanistically not resolved","Direct target sets incompletely catalogued"]},{"year":2014,"claim":"Mapped EWSR1 recruitment of Aurora B to the midzone via the RGG3 R565 residue, providing a molecular basis for its role in cytokinesis and ploidy control.","evidence":"siRNA knockdown, midzone imaging, Co-IP, domain/point mutation and rescue","pmids":["25483190"],"confidence":"Medium","gaps":["Whether methylation of R565 regulates the interaction untested","Reciprocal validation of Aurora B interaction limited"]},{"year":2015,"claim":"Defined EWS-FLI1 as a splicing regulatory hub binding nascent RNA and spliceosomal factors, and showed RHA helicase inhibition by the fusion, with both reversible by YK-4-279.","evidence":"CLIP-seq, exon array/RNA-seq, Co-IP with DDX5/hnRNP K/PRPF6, in vitro helicase/ATPase assays, enantiomer-specific inhibition","pmids":["25737553","25564528"],"confidence":"High","gaps":["Splicing role of wild-type EWSR1 not directly compared","In vivo significance of altered isoforms incompletely tested"]},{"year":2018,"claim":"Established that EWSR1 suppresses R-loops to enable homologous recombination, and that the fusion's transcriptional excess drives R-loop-associated replication stress and HR defects.","evidence":"S9.6 R-loop immunofluorescence, BRCA1 Co-IP with transcription machinery, knockdown/rescue, DNA damage and replication stress assays","pmids":["29513652"],"confidence":"High","gaps":["Direct RNA/DNA species bound by EWSR1 at R-loops not fully defined","How EWSR1 dislodges BRCA1 from elongation machinery unresolved"]},{"year":2015,"claim":"Showed EWSR1 stabilizes PGC-1α by limiting FBXW7-mediated degradation, linking the protein to mitochondrial biogenesis in multiple tissues.","evidence":"Ews knockout mice, ubiquitination assay, proteasome and Fbxw7 knockdown rescue, mitochondrial measurements","pmids":["25918410"],"confidence":"High","gaps":["Direct molecular step by which EWSR1 limits FBXW7 unknown","Whether EWSR1 acts on PGC-1α transcription or protein directly not fully separated"]},{"year":2019,"claim":"Identified deubiquitinase- and ligase-based control of fusion protein abundance, establishing EWS-FLI1 stability as a druggable dependency.","evidence":"siRNA/CRISPR screens, Co-IP, ubiquitination and phosphorylation assays, xenografts (USP19, TRIM8, SPOP/OTUD7A)","pmids":["30700749","34329586","34060252"],"confidence":"High","gaps":["Whether these enzymes also regulate wild-type EWSR1 partly unresolved","Interplay among the competing ligases/DUBs not integrated"]},{"year":2021,"claim":"Linked the low-complexity domain to formation of cellular protein assemblies required for the fusion's broad partner network including RNA Pol II, bridging biochemistry to gene regulation.","evidence":"cross-linking assembly assay, domain deletion, siRNA knockdown, RNA-seq","pmids":["34035145"],"confidence":"Medium","gaps":["Whether assemblies are bona fide phase-separated condensates not proven here","Composition of assemblies not exhaustively defined"]},{"year":2023,"claim":"Defined EWSR1 as a centromere identity factor acting through CENP-A binding via SYGQ2 and R-loop binding via its RRM, connecting its disordered and RNA-binding modules to chromosome segregation.","evidence":"Co-IP, CENP-A ChIP after depletion, in vitro R-loop binding, domain mutation analysis, immunofluorescence","pmids":["37243594"],"confidence":"Medium","gaps":["Mechanism by which EWSR1 retains CENP-A not resolved","In vivo significance for chromosome segregation not fully tested"]},{"year":2024,"claim":"Provided molecular detail that tyrosine residues drive phase separation of the EWS low-complexity domain, defining the sequence determinants of its condensate behavior.","evidence":"PRE-NMR, microscopy, all-atom MD simulations, tyrosine mutational analysis","pmids":["38492239"],"confidence":"Medium","gaps":["Cellular function of these condensates not directly tested","Link to transactivation strength of full-length protein not established"]},{"year":null,"claim":"How arginine methylation, tyrosine-driven phase separation, and the competing ubiquitination/deubiquitination network are integrated to coordinate EWSR1's transcription, splicing, centromere, R-loop, and mitochondrial functions remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking modifications to specific functional outputs","Substrate/target specificity of wild-type vs fusion incompletely separated","Structural basis of higher-order assembly in cells undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[5,21,22,31]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,18]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,16,17]},{"term_id":"GO:0045182","term_label":"translation regulator activity","supporting_discovery_ids":[15,21]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[20,23]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,16,17]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[4,6]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[31]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[10,20]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[16,17]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[15,21]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[24]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[10,20,31]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[17,26]}],"complexes":[],"partners":["FLI1","DHX9","DDX5","HNRNPK","PRPF6","REST","AURKB","LMNA"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q01844","full_name":"RNA-binding protein EWS","aliases":["EWS oncogene","Ewing sarcoma breakpoint region 1 protein"],"length_aa":656,"mass_kda":68.5,"function":"Binds to ssRNA containing the consensus sequence 5'-AGGUAA-3' (PubMed:21256132). Might normally function as a transcriptional repressor (PubMed:10767297). EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes","subcellular_location":"Nucleus; Cytoplasm; Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q01844/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/EWSR1","classification":"Common Essential","n_dependent_lines":1193,"n_total_lines":1208,"dependency_fraction":0.9875827814569537},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000182944","cell_line_id":"CID000989","localizations":[{"compartment":"nuclear_punctae","grade":3},{"compartment":"nucleoplasm","grade":3},{"compartment":"nucleolus_fc_dfc","grade":1}],"interactors":[{"gene":"CAPZB","stoichiometry":0.2},{"gene":"TFAP2A","stoichiometry":0.2},{"gene":"TRAF3","stoichiometry":0.2},{"gene":"MRPL39","stoichiometry":0.2},{"gene":"TNPO1","stoichiometry":0.2},{"gene":"CPNE2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000989","total_profiled":1310},"omim":[{"mim_id":"619327","title":"LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15; LRRC15","url":"https://www.omim.org/entry/619327"},{"mim_id":"616492","title":"EWING SARCOMA-ASSOCIATED TRANSCRIPT 1, NONCODING; EWSAT1","url":"https://www.omim.org/entry/616492"},{"mim_id":"614392","title":"TUDOR DOMAIN-CONTAINING PROTEIN 3; TDRD3","url":"https://www.omim.org/entry/614392"},{"mim_id":"613844","title":"UBIQUINOL-CYTOCHROME C REDUCTASE HINGE PROTEIN; UQCRH","url":"https://www.omim.org/entry/613844"},{"mim_id":"612237","title":"CHONDROSARCOMA, EXTRASKELETAL MYXOID","url":"https://www.omim.org/entry/612237"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/EWSR1"},"hgnc":{"alias_symbol":["EWS"],"prev_symbol":[]},"alphafold":{"accession":"Q01844","domains":[{"cath_id":"3.30.70.330","chopping":"363-445","consensus_level":"high","plddt":84.6145,"start":363,"end":445},{"cath_id":"2.20.28","chopping":"522-550","consensus_level":"medium","plddt":85.1738,"start":522,"end":550}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q01844","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q01844-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q01844-F1-predicted_aligned_error_v6.png","plddt_mean":50.41},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=EWSR1","jax_strain_url":"https://www.jax.org/strain/search?query=EWSR1"},"sequence":{"accession":"Q01844","fasta_url":"https://rest.uniprot.org/uniprotkb/Q01844.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q01844/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q01844"}},"corpus_meta":[{"pmid":"25453903","id":"PMC_25453903","title":"EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma.","date":"2014","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/25453903","citation_count":363,"is_preprint":false},{"pmid":"11607824","id":"PMC_11607824","title":"Biology of EWS/ETS fusions in Ewing's family tumors.","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11607824","citation_count":277,"is_preprint":false},{"pmid":"35031058","id":"PMC_35031058","title":"EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3.","date":"2022","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35031058","citation_count":263,"is_preprint":false},{"pmid":"29513652","id":"PMC_29513652","title":"EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/29513652","citation_count":261,"is_preprint":false},{"pmid":"8637704","id":"PMC_8637704","title":"Fusion of the EWS and CHOP genes in myxoid liposarcoma.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8637704","citation_count":237,"is_preprint":false},{"pmid":"22510762","id":"PMC_22510762","title":"Tumors with EWSR1-CREB1 and EWSR1-ATF1 fusions: the current status.","date":"2012","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22510762","citation_count":195,"is_preprint":false},{"pmid":"18094413","id":"PMC_18094413","title":"EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma.","date":"2007","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/18094413","citation_count":168,"is_preprint":false},{"pmid":"7503813","id":"PMC_7503813","title":"EWS/Fli-1 chimeric protein is a transcriptional activator.","date":"1993","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/7503813","citation_count":159,"is_preprint":false},{"pmid":"8040301","id":"PMC_8040301","title":"EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations.","date":"1994","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/8040301","citation_count":139,"is_preprint":false},{"pmid":"16202544","id":"PMC_16202544","title":"EWS-ETS oncoproteins: the linchpins of Ewing tumors.","date":"2005","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/16202544","citation_count":136,"is_preprint":false},{"pmid":"29358035","id":"PMC_29358035","title":"EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma.","date":"2018","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/29358035","citation_count":134,"is_preprint":false},{"pmid":"31709724","id":"PMC_31709724","title":"Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.","date":"2019","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31709724","citation_count":133,"is_preprint":false},{"pmid":"24320889","id":"PMC_24320889","title":"The diversity of soft tissue tumours with EWSR1 gene rearrangements: a review.","date":"2013","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/24320889","citation_count":125,"is_preprint":false},{"pmid":"20547696","id":"PMC_20547696","title":"Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma.","date":"2010","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/20547696","citation_count":123,"is_preprint":false},{"pmid":"25737553","id":"PMC_25737553","title":"Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25737553","citation_count":121,"is_preprint":false},{"pmid":"19936782","id":"PMC_19936782","title":"Soft tissue tumors associated with EWSR1 translocation.","date":"2010","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19936782","citation_count":119,"is_preprint":false},{"pmid":"17415412","id":"PMC_17415412","title":"Ewing sarcoma gene EWS is essential for meiosis and B lymphocyte development.","date":"2007","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/17415412","citation_count":119,"is_preprint":false},{"pmid":"24441665","id":"PMC_24441665","title":"Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.","date":"2014","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24441665","citation_count":117,"is_preprint":false},{"pmid":"11709708","id":"PMC_11709708","title":"Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation.","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11709708","citation_count":115,"is_preprint":false},{"pmid":"16740692","id":"PMC_16740692","title":"Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16740692","citation_count":113,"is_preprint":false},{"pmid":"7517940","id":"PMC_7517940","title":"The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7517940","citation_count":111,"is_preprint":false},{"pmid":"32770123","id":"PMC_32770123","title":"EWSR1/FUS-CREB fusions define a distinctive malignant epithelioid neoplasm with predilection for mesothelial-lined cavities.","date":"2020","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/32770123","citation_count":100,"is_preprint":false},{"pmid":"15826834","id":"PMC_15826834","title":"The EWS-WT1 gene fusion in desmoplastic small round cell tumor.","date":"2005","source":"Seminars in cancer biology","url":"https://pubmed.ncbi.nlm.nih.gov/15826834","citation_count":99,"is_preprint":false},{"pmid":"34329586","id":"PMC_34329586","title":"TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma.","date":"2021","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/34329586","citation_count":94,"is_preprint":false},{"pmid":"31189996","id":"PMC_31189996","title":"Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma.","date":"2019","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/31189996","citation_count":92,"is_preprint":false},{"pmid":"11301318","id":"PMC_11301318","title":"EWS/FLI alters 5'-splice site selection.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11301318","citation_count":84,"is_preprint":false},{"pmid":"30481590","id":"PMC_30481590","title":"EWSR1, a multifunctional protein, regulates cellular function and aging via genetic and epigenetic pathways.","date":"2018","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/30481590","citation_count":78,"is_preprint":false},{"pmid":"11278906","id":"PMC_11278906","title":"Exposure on cell surface and extensive arginine methylation of ewing sarcoma (EWS) protein.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278906","citation_count":77,"is_preprint":false},{"pmid":"16556028","id":"PMC_16556028","title":"Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.","date":"2005","source":"Future oncology (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16556028","citation_count":72,"is_preprint":false},{"pmid":"25706482","id":"PMC_25706482","title":"Novel FUS-KLF17 and EWSR1-KLF17 fusions in myoepithelial tumors.","date":"2015","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25706482","citation_count":71,"is_preprint":false},{"pmid":"28643791","id":"PMC_28643791","title":"EWSR1 fusion proteins mediate PAX7 expression in Ewing sarcoma.","date":"2017","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/28643791","citation_count":70,"is_preprint":false},{"pmid":"30379650","id":"PMC_30379650","title":"Spindle and Round Cell Sarcoma With EWSR1-PATZ1 Gene Fusion: A Sarcoma With Polyphenotypic Differentiation.","date":"2019","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30379650","citation_count":68,"is_preprint":false},{"pmid":"23329308","id":"PMC_23329308","title":"Molecular detection and targeting of EWSR1 fusion transcripts in soft tissue tumors.","date":"2013","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23329308","citation_count":66,"is_preprint":false},{"pmid":"23630070","id":"PMC_23630070","title":"RNA sequencing identifies fusion of the EWSR1 and YY1 genes in mesothelioma with t(14;22)(q32;q12).","date":"2013","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23630070","citation_count":63,"is_preprint":false},{"pmid":"29679497","id":"PMC_29679497","title":"EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity.","date":"2018","source":"Brain pathology (Zurich, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/29679497","citation_count":62,"is_preprint":false},{"pmid":"34060252","id":"PMC_34060252","title":"SPOP and OTUD7A Control EWS-FLI1 Protein Stability to Govern Ewing Sarcoma Growth.","date":"2021","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/34060252","citation_count":60,"is_preprint":false},{"pmid":"26848860","id":"PMC_26848860","title":"Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26848860","citation_count":60,"is_preprint":false},{"pmid":"30895378","id":"PMC_30895378","title":"DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.","date":"2019","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30895378","citation_count":60,"is_preprint":false},{"pmid":"31049020","id":"PMC_31049020","title":"EWSR1-NFATC2 and FUS-NFATC2 Gene Fusion-Associated Mesenchymal Tumors: Clinicopathologic Correlation and Literature Review.","date":"2019","source":"Sarcoma","url":"https://pubmed.ncbi.nlm.nih.gov/31049020","citation_count":57,"is_preprint":false},{"pmid":"29898995","id":"PMC_29898995","title":"EWS/ETS-Driven Ewing Sarcoma Requires BET Bromodomain Proteins.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29898995","citation_count":57,"is_preprint":false},{"pmid":"30709442","id":"PMC_30709442","title":"Mesenchymal Tumors with EWSR1 Gene Rearrangements.","date":"2019","source":"Surgical pathology clinics","url":"https://pubmed.ncbi.nlm.nih.gov/30709442","citation_count":54,"is_preprint":false},{"pmid":"11553628","id":"PMC_11553628","title":"DNA binding domain-independent pathways are involved in EWS/FLI1-mediated oncogenesis.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11553628","citation_count":53,"is_preprint":false},{"pmid":"18855877","id":"PMC_18855877","title":"The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.","date":"2009","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18855877","citation_count":53,"is_preprint":false},{"pmid":"17912356","id":"PMC_17912356","title":"Ewing sarcoma protein ewsr1 maintains mitotic integrity and proneural cell survival in the zebrafish embryo.","date":"2007","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/17912356","citation_count":52,"is_preprint":false},{"pmid":"15491164","id":"PMC_15491164","title":"Recombinant EWS-FLI1 oncoprotein activates transcription.","date":"2004","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15491164","citation_count":51,"is_preprint":false},{"pmid":"31392992","id":"PMC_31392992","title":"EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/31392992","citation_count":51,"is_preprint":false},{"pmid":"38492239","id":"PMC_38492239","title":"Insights into Molecular Diversity within the FUS/EWS/TAF15 Protein Family: Unraveling Phase Separation of the N-Terminal Low-Complexity Domain from RNA-Binding Protein EWS.","date":"2024","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/38492239","citation_count":49,"is_preprint":false},{"pmid":"26258070","id":"PMC_26258070","title":"EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma.","date":"2015","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/26258070","citation_count":49,"is_preprint":false},{"pmid":"26623725","id":"PMC_26623725","title":"Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26623725","citation_count":48,"is_preprint":false},{"pmid":"30723142","id":"PMC_30723142","title":"Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent Manner.","date":"2019","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/30723142","citation_count":46,"is_preprint":false},{"pmid":"7591257","id":"PMC_7591257","title":"EWS-FLI-1 and EWS-ERG chimeric mRNAs in Ewing's sarcoma and primitive neuroectodermal tumor.","date":"1995","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/7591257","citation_count":46,"is_preprint":false},{"pmid":"12923058","id":"PMC_12923058","title":"Identification of a DNA-binding site and transcriptional target for the EWS-WT1(+KTS) oncoprotein.","date":"2003","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12923058","citation_count":45,"is_preprint":false},{"pmid":"21030557","id":"PMC_21030557","title":"Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21030557","citation_count":44,"is_preprint":false},{"pmid":"14534527","id":"PMC_14534527","title":"Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein.","date":"2003","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/14534527","citation_count":43,"is_preprint":false},{"pmid":"23281395","id":"PMC_23281395","title":"EWS/ATF1 expression induces sarcomas from neural crest-derived cells in mice.","date":"2013","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/23281395","citation_count":43,"is_preprint":false},{"pmid":"19074838","id":"PMC_19074838","title":"EWS-Fli1 up-regulates expression of the Aurora A and Aurora B kinases.","date":"2008","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/19074838","citation_count":43,"is_preprint":false},{"pmid":"36124657","id":"PMC_36124657","title":"EWS/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/36124657","citation_count":42,"is_preprint":false},{"pmid":"36658219","id":"PMC_36658219","title":"ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation.","date":"2023","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36658219","citation_count":41,"is_preprint":false},{"pmid":"23459838","id":"PMC_23459838","title":"What the EWSR1-ATF1 fusion has taught us about hyalinizing clear cell carcinoma.","date":"2013","source":"Head and neck pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23459838","citation_count":41,"is_preprint":false},{"pmid":"31135487","id":"PMC_31135487","title":"Cutaneous Syncytial Myoepithelioma Is Characterized by Recurrent EWSR1-PBX3 Fusions.","date":"2019","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31135487","citation_count":40,"is_preprint":false},{"pmid":"35477713","id":"PMC_35477713","title":"EWSR1-ATF1 dependent 3D connectivity regulates oncogenic and differentiation programs in Clear Cell Sarcoma.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35477713","citation_count":37,"is_preprint":false},{"pmid":"25564528","id":"PMC_25564528","title":"RNA helicase A activity is inhibited by oncogenic transcription factor EWS-FLI1.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/25564528","citation_count":37,"is_preprint":false},{"pmid":"24185621","id":"PMC_24185621","title":"A multifunctional protein EWS regulates the expression of Drosha and microRNAs.","date":"2013","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/24185621","citation_count":36,"is_preprint":false},{"pmid":"12432241","id":"PMC_12432241","title":"EWS-FLI1 and Ewing's sarcoma: recent molecular data and new insights.","date":"2002","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/12432241","citation_count":36,"is_preprint":false},{"pmid":"33316098","id":"PMC_33316098","title":"Identification of EWSR1-NFATC2 fusion in simple bone cysts.","date":"2021","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/33316098","citation_count":35,"is_preprint":false},{"pmid":"24934812","id":"PMC_24934812","title":"EWS-WT1 oncoprotein activates neuronal reprogramming factor ASCL1 and promotes neural differentiation.","date":"2014","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24934812","citation_count":35,"is_preprint":false},{"pmid":"33080033","id":"PMC_33080033","title":"EWS-FLI1 regulates and cooperates with core regulatory circuitry in Ewing sarcoma.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/33080033","citation_count":34,"is_preprint":false},{"pmid":"30700749","id":"PMC_30700749","title":"USP19 deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30700749","citation_count":32,"is_preprint":false},{"pmid":"15273724","id":"PMC_15273724","title":"Role of protein-protein interactions in the antiapoptotic function of EWS-Fli-1.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15273724","citation_count":32,"is_preprint":false},{"pmid":"25918410","id":"PMC_25918410","title":"Inactivation of EWS reduces PGC-1α protein stability and mitochondrial homeostasis.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25918410","citation_count":31,"is_preprint":false},{"pmid":"12915128","id":"PMC_12915128","title":"Expression and subcellular localization of Ewing sarcoma (EWS) protein is affected by the methylation process.","date":"2003","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/12915128","citation_count":30,"is_preprint":false},{"pmid":"26961871","id":"PMC_26961871","title":"Englerin A Inhibits EWS-FLI1 DNA Binding in Ewing Sarcoma Cells.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26961871","citation_count":30,"is_preprint":false},{"pmid":"34976713","id":"PMC_34976713","title":"One oncogene, several vulnerabilities: EWS/FLI targeted therapies for Ewing sarcoma.","date":"2021","source":"Journal of bone oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34976713","citation_count":30,"is_preprint":false},{"pmid":"33097530","id":"PMC_33097530","title":"RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/33097530","citation_count":29,"is_preprint":false},{"pmid":"35653119","id":"PMC_35653119","title":"EWS::FLI1 and HOXD13 Control Tumor Cell Plasticity in Ewing Sarcoma.","date":"2022","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/35653119","citation_count":28,"is_preprint":false},{"pmid":"23399793","id":"PMC_23399793","title":"Cutaneous neoplasms showing EWSR1 rearrangement.","date":"2013","source":"Advances in anatomic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23399793","citation_count":27,"is_preprint":false},{"pmid":"34035145","id":"PMC_34035145","title":"Fusion protein EWS-FLI1 is incorporated into a protein granule in cells.","date":"2021","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/34035145","citation_count":27,"is_preprint":false},{"pmid":"18271016","id":"PMC_18271016","title":"EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing's sarcoma cells.","date":"2008","source":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/18271016","citation_count":27,"is_preprint":false},{"pmid":"21344536","id":"PMC_21344536","title":"mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma.","date":"2011","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21344536","citation_count":26,"is_preprint":false},{"pmid":"26573619","id":"PMC_26573619","title":"EWS and FUS bind a subset of transcribed genes encoding proteins enriched in RNA regulatory functions.","date":"2015","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/26573619","citation_count":26,"is_preprint":false},{"pmid":"36357572","id":"PMC_36357572","title":"Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/36357572","citation_count":23,"is_preprint":false},{"pmid":"36672331","id":"PMC_36672331","title":"Regulation of EWSR1-FLI1 Function by Post-Transcriptional and Post-Translational Modifications.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/36672331","citation_count":22,"is_preprint":false},{"pmid":"27627705","id":"PMC_27627705","title":"EWSR1/ELF5 induces acute myeloid leukemia by inhibiting p53/p21 pathway.","date":"2016","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/27627705","citation_count":22,"is_preprint":false},{"pmid":"31036566","id":"PMC_31036566","title":"EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival.","date":"2019","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31036566","citation_count":22,"is_preprint":false},{"pmid":"35768243","id":"PMC_35768243","title":"EWSR1-TFCP2 in an adolescent represents an extremely rare and aggressive form of intraosseous spindle cell rhabdomyosarcomas.","date":"2022","source":"Cold Spring Harbor molecular case studies","url":"https://pubmed.ncbi.nlm.nih.gov/35768243","citation_count":22,"is_preprint":false},{"pmid":"37894854","id":"PMC_37894854","title":"EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37894854","citation_count":21,"is_preprint":false},{"pmid":"37243594","id":"PMC_37243594","title":"EWSR1 maintains centromere identity.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37243594","citation_count":20,"is_preprint":false},{"pmid":"26336820","id":"PMC_26336820","title":"PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26336820","citation_count":20,"is_preprint":false},{"pmid":"22973553","id":"PMC_22973553","title":"Acetylation Increases EWS-FLI1 DNA Binding and Transcriptional Activity.","date":"2012","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22973553","citation_count":20,"is_preprint":false},{"pmid":"36585419","id":"PMC_36585419","title":"MANF/EWSR1/ANXA6 pathway might as the bridge between hypolipidemia and major depressive disorder.","date":"2022","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/36585419","citation_count":19,"is_preprint":false},{"pmid":"24069508","id":"PMC_24069508","title":"EWS and RE1-Silencing Transcription Factor Inhibit Neuronal Phenotype Development and Oncogenic Transformation in Ewing Sarcoma.","date":"2013","source":"Genes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24069508","citation_count":19,"is_preprint":false},{"pmid":"38043789","id":"PMC_38043789","title":"Sarcomas Harboring EWSR1::PATZ1 Fusions: A Clinicopathologic Study of 17 Cases.","date":"2023","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/38043789","citation_count":18,"is_preprint":false},{"pmid":"17564582","id":"PMC_17564582","title":"The EWS-Oct-4 fusion gene encodes a transforming gene.","date":"2007","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/17564582","citation_count":18,"is_preprint":false},{"pmid":"32164354","id":"PMC_32164354","title":"High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing Sarcoma.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32164354","citation_count":18,"is_preprint":false},{"pmid":"25483190","id":"PMC_25483190","title":"Ewing sarcoma EWS protein regulates midzone formation by recruiting Aurora B kinase to the midzone.","date":"2014","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/25483190","citation_count":18,"is_preprint":false},{"pmid":"34885181","id":"PMC_34885181","title":"EWSR1-WT1 Target Genes and Therapeutic Options Identified in a Novel DSRCT In Vitro Model.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34885181","citation_count":18,"is_preprint":false},{"pmid":"37627063","id":"PMC_37627063","title":"Targeted Therapy for EWS-FLI1 in Ewing Sarcoma.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/37627063","citation_count":16,"is_preprint":false},{"pmid":"31050844","id":"PMC_31050844","title":"EWSR1 translocation in primary hyalinising clear cell carcinoma of the thymus.","date":"2019","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/31050844","citation_count":16,"is_preprint":false},{"pmid":"34956445","id":"PMC_34956445","title":"Challenges in modeling EWS-FLI1-driven transgenic mouse model for Ewing sarcoma.","date":"2021","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/34956445","citation_count":16,"is_preprint":false},{"pmid":"37405123","id":"PMC_37405123","title":"Targeting the Clear Cell Sarcoma Oncogenic Driver Fusion Gene EWSR1::ATF1 by HDAC Inhibition.","date":"2023","source":"Cancer research communications","url":"https://pubmed.ncbi.nlm.nih.gov/37405123","citation_count":15,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48706,"output_tokens":8125,"usd":0.133996,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17622,"output_tokens":6489,"usd":0.125167,"stage2_stop_reason":"end_turn"},"total_usd":0.259163,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"EWS-FLI1 chimeric protein functions as a transcriptional activator; deletion analysis revealed that the EWS N-terminal domain (NTD-EWS) acts as a modulatory/regulatory domain for the transcriptional activation properties of the C-terminal FLI1 activation domain of EWS-FLI1, not as an autonomous activator.\",\n      \"method\": \"Transcriptional reporter assays and deletion analysis in cell transfection experiments\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reporter assays with deletion constructs in a single study, foundational mechanistic result\",\n      \"pmids\": [\"7503813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"EWS-FLI1 protein displays the same DNA-binding specificity and affinity as wild-type FLI1, with the consensus binding site ACCGGAAG/aT/c; the Ets domain is necessary and sufficient for the DNA-binding specificity of the fusion protein.\",\n      \"method\": \"Epitope-tagged protein binding site selection, truncation mutant DNA-binding assays in vitro\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro DNA-binding assay with truncation mutants, single lab\",\n      \"pmids\": [\"7517940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"EWS and EWS-FLI1 interact with SF1 and U1C, essential components of the splicing machinery; EWS-FLI1 (but not EWS alone) interferes with hnRNP A1-dependent 5'-splice site selection in an E1A in vivo splicing assay, and this splicing-altering activity coincides with transforming activity.\",\n      \"method\": \"In vivo splicing assay (E1A gene), mutational analysis, protein interaction assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo splicing assay with mutational analysis, single lab, two orthogonal methods\",\n      \"pmids\": [\"11301318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"EWS-FLI1 activates oncogenic pathways independent of its ETS DNA-binding domain (DBD); DBD point mutants and large deletions retain tumor acceleration in NIH 3T3 cells in vivo, while losing DNA binding in vitro, demonstrating DBD-independent oncogenic signaling.\",\n      \"method\": \"In vivo tumor assay in NIH 3T3 / SCID mice, dominant-negative FLI1 constructs, in vitro DNA-binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo tumorigenesis assay combined with in vitro binding assays, single lab\",\n      \"pmids\": [\"11553628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"EWS protein is extensively and asymmetrically dimethylated on arginine residues within its RGG motifs (29 of 30 Arg-Gly sites at least partially methylated); the protein is also present on the cell surface in addition to the nucleus and cytosol.\",\n      \"method\": \"Cell-surface biotinylation, isoelectric focusing, avidin-agarose extraction, MALDI and nanoelectrospray tandem mass spectrometry of in-gel-digested peptides\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mass spectrometric mapping of modification sites with rigorous biochemical fractionation, comprehensive mapping of 29/30 sites\",\n      \"pmids\": [\"11278906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"EWS protein self-associates through its C-terminal RNA-binding domain in an RNA-dependent manner (sensitive to RNaseA); EWS-FLI1 can also self-associate and interact with FLI1 via its C-terminal FLI1 domain in an RNA-independent manner; the EWS N-terminal domain mediates both homotypic and heterotypic interactions of EWS and EWS-FLI1.\",\n      \"method\": \"FRET, mammalian two-hybrid assay, GST pull-down, immunoprecipitation, RNaseA sensitivity assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — four orthogonal methods (FRET, MTH, GST pulldown, Co-IP), single lab but comprehensive mechanistic dissection\",\n      \"pmids\": [\"14534527\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Methylation process controls EWS protein expression and subcellular localization: inhibition of methylation with adenosine dialdehyde decreases EWS protein in both the nucleus and cell surface; mitogenic stimulation of normal T cells increases methylated EWS on the cell surface ~10-fold.\",\n      \"method\": \"Cell-surface biotinylation, immunoblotting after methylation inhibitor treatment, mitogenic stimulation of PBMC\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — pharmacological inhibition and stimulation experiments, single lab, two orthogonal approaches\",\n      \"pmids\": [\"12915128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"EWS-FLI1 purified as recombinant protein from E. coli adopts a largely unfolded conformation under native conditions, yet specifically binds DNA and activates transcription, confirming its intrinsically disordered nature and transcriptional activity.\",\n      \"method\": \"Recombinant protein purification, circular dichroism, fluorescence spectroscopy, in vitro DNA-binding and transcription assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with biophysical characterization and functional assays, single lab\",\n      \"pmids\": [\"15491164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"EWS-FLI1 directly binds RNA helicase A (RHA) at the region spanning amino acids 630–1020 of RHA; endogenous RHA co-immunoprecipitates with EWS-FLI1 in ESFT cell lines; RHA and EWS-FLI1 co-occupy target gene promoters (e.g., Id2) by ChIP; RHA stimulates EWS-FLI1 transcriptional activity and enhances anchorage-independent transformation.\",\n      \"method\": \"Phage display, GST pull-down, ELISA, reciprocal Co-IP, chromatin immunoprecipitation, luciferase reporter assay, anchorage-independent growth assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (phage display, GST pulldown, Co-IP, ChIP, reporter assay, transformation assay), single lab\",\n      \"pmids\": [\"16740692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"EWS is required for completion of B cell development and meiosis in vivo: Ews-null mice show cell-autonomous defects in pre-B lymphocyte development, spermatocyte XY bivalent formation failure, and massive apoptosis during meiosis. Loss of EWS also results in premature senescence of mouse embryonic fibroblasts and hypersensitivity to ionizing radiation. EWS interacts with lamin A/C and its loss reduces lamin A/C expression.\",\n      \"method\": \"Ews knockout mice generation, lymphocyte analysis, meiosis analysis, MEF senescence assays, ionizing radiation sensitivity assay, co-immunoprecipitation (EWS–lamin A/C interaction), immunoblotting\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with multiple defined phenotypes plus Co-IP for binding partner, comprehensive in vivo study\",\n      \"pmids\": [\"17415412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"EWSR1 maintains mitotic integrity: morpholino knockdown of zebrafish ewsr1a/ewsr1b causes multipolar or abnormal mitotic spindles followed by p53-mediated apoptosis in the CNS; siRNA silencing of EWSR1 in HeLa cells causes mitotic defects and apoptosis, confirming conservation of this function.\",\n      \"method\": \"Morpholino knockdown in zebrafish, siRNA knockdown in HeLa cells, mitotic spindle imaging\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two model systems with defined spindle phenotype, single lab\",\n      \"pmids\": [\"17912356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"EWS-ATF1 fusion protein, when expressed from the EWS promoter in mice, directly induces FOS expression in an ERK-independent manner; EWS/ATF1 expression is sufficient to transform neural crest-derived cells and produce CCS-like sarcomas in vivo.\",\n      \"method\": \"Inducible transgenic mouse model, lineage-tracing experiments, siRNA knockdown of FOS, promoter analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic mouse with lineage tracing and direct target (FOS) validation, single lab\",\n      \"pmids\": [\"23281395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The EWSR1/NR4A3 fusion protein directly activates the PPARG promoter through a specific DNA response element; band-shift experiments confirm EWSR1/NR4A3 binding to this element, and a truncated native NR4A3 isoform can negatively regulate the fusion protein's activity on this promoter.\",\n      \"method\": \"Expression microarray, western blot/IHC validation, band-shift (EMSA) assays, transient transfection reporter assays, bioinformatic promoter analysis\",\n      \"journal\": \"The Journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA and reporter assay with mutagenesis-level promoter dissection, single lab\",\n      \"pmids\": [\"18855877\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Endogenous EWS is required for hematopoietic stem cell quiescence; Ews-deficient hematopoietic stem/progenitor cells undergo early senescence with increased p16INK4a and senescence-associated β-galactosidase activity.\",\n      \"method\": \"Ews knockout mice, flow cytometry of HSPCs, β-galactosidase senescence assay, p16INK4a immunoblotting\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with defined cellular phenotype, single lab\",\n      \"pmids\": [\"21030557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Acetylation of the C-terminal FLI1 DNA-binding domain of EWS-FLI1 increases its DNA-binding activity in vitro; overexpression of PCAF or treatment with HDAC inhibitors increases EWS-FLI1 transcriptional activity in co-transfection assays.\",\n      \"method\": \"In vitro acetylation assay, EMSA, luciferase reporter assay, PCAF overexpression, HDAC inhibitor treatment\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro acetylation with binding assay and cell-based reporter, single lab; full-length EWS-FLI1 acetylation in ES cells unclear\",\n      \"pmids\": [\"22973553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"EWS regulates expression of Drosha (a miRNA microprocessor): EWS deficiency increases Drosha expression, elevating miR-29b and miR-18b levels, which post-transcriptionally repress Col4a1 and CTGF, contributing to dermal developmental defects. Knockdown of Drosha rescues miRNA-dependent downregulation of these targets.\",\n      \"method\": \"Ews knockout mouse embryonic fibroblasts, qPCR for miRNA levels, Drosha knockdown rescue experiment, immunoblotting for Col4a1 and CTGF\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with rescue experiment, mechanistic pathway validated by Drosha knockdown, single lab\",\n      \"pmids\": [\"24185621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Wild-type EWS interacts directly with REST (RE1-Silencing Transcription Factor) by co-immunoprecipitation; genome-wide ChIP shows EWS binds chromatin at/near NRSE (neuron-restrictive silencer element) sites; EWS and REST cooperatively suppress neuronal gene expression and oncogenic transformation in Ewing sarcoma cells.\",\n      \"method\": \"Co-immunoprecipitation, ChIP-seq, RNA-seq after RNAi, functional transformation assays\",\n      \"journal\": \"Genes & cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus ChIP-seq and functional KD assays, single lab\",\n      \"pmids\": [\"24069508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"EWS-FLI1 reprograms gene regulatory circuits by two divergent mechanisms: (1) at GGAA repeat elements EWS-FLI1 multimers induce chromatin opening and create de novo enhancers that physically interact with target promoters; (2) at conserved ETS-motif enhancers EWS-FLI1 displaces wild-type ETS factors to inactivate them.\",\n      \"method\": \"ChIP-seq, ATAC-seq/DNaseI-seq, chromatin conformation capture, EWS-FLI1 knockdown/rescue, luciferase reporter assays\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal epigenomic methods with knockdown/rescue and chromatin looping confirmation, rigorous mechanistic dissection\",\n      \"pmids\": [\"25453903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"EWS-WT1(+KTS) fusion protein directly binds the sequence 5'-GGAGG(A/G)-3' upstream of the LRRC15 gene and transactivates it; this binding site differs from known WT1 consensus sites, demonstrating that the +KTS insertion abrogates canonical WT1 binding but confers a new specificity.\",\n      \"method\": \"cDNA subtractive hybridization, in vitro and in vivo DNA binding assays, ChIP, mutagenesis of binding element, inducible expression system\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro and in vivo binding with mutagenesis, ChIP, and inducible expression system in a single rigorous study\",\n      \"pmids\": [\"12923058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"EWS-WT1 directly binds the proximal promoter of ASCL1 through multiple WT1-responsive elements and activates ASCL1 transcription, inducing a neural gene expression program and partial neural differentiation in DSRCT cells.\",\n      \"method\": \"Transgenic mouse model (EWS-WT1 under native Ews promoter), promoter-binding assays, ASCL1 knockdown, inducible expression in primary fibroblasts\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic model with direct promoter binding assay and KD rescue, single lab\",\n      \"pmids\": [\"24934812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"EWS interacts with Aurora B kinase via the R565 residue in its RGG3 domain, and EWS is required for recruiting Aurora B to the midzone during anaphase; loss of EWS or EWS-FLI1 expression causes midzone defects and aneuploidy; ectopic EWS expression rescues midzone defects in Ewing sarcoma cells.\",\n      \"method\": \"siRNA knockdown, immunofluorescence/live imaging of midzone, co-immunoprecipitation, domain deletion/point mutation analysis, rescue experiments\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with domain mutagenesis and functional rescue, single lab\",\n      \"pmids\": [\"25483190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"EWS-FLI1 acts as a splicing regulatory hub: it binds RNA at intron-exon boundaries (CLIP-seq), interacts with spliceosomal proteins DDX5, hnRNP K, and PRPF6, and produces alternative splicing of CLK1, CASP3, PPFIBP1, and TERT isoforms; the small molecule YK-4-279 disrupts EWS-FLI1 interactions with DDX5 and RHA, reversing splicing alterations.\",\n      \"method\": \"CLIP-seq, exon array, RNA-seq, Co-IP with splicing factors, YK-4-279 inhibitor treatment, telomerase activity assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (CLIP-seq, Co-IP, RNA-seq, pharmacological inhibition with reversal of phenotype), single lab\",\n      \"pmids\": [\"25737553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"EWS-FLI1 inhibits RNA helicase A (RHA) helicase activity in a dose-dependent manner without affecting ATPase activity; EWS-FLI1 has RNA-binding activity and alters the RNA-binding profile of RHA; the (S)-enantiomer of YK-4-279 specifically reverses EWS-FLI1 inhibition of RHA helicase activity.\",\n      \"method\": \"In vitro helicase activity assay, ATPase assay, RNA-binding assay, separated enantiomer treatment\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic assays with dose-response and enantiomer specificity, single lab\",\n      \"pmids\": [\"25564528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Loss of EWS leads to rapid proteasomal degradation of PGC-1α via increased FBXW7 E3 ubiquitin ligase expression; EWS inactivation causes significant reduction in mitochondrial abundance and activity in MEFs, brown fat, and skeletal muscle; complementation of EWS restores PGC-1α and mitochondrial abundance; depletion of Fbxw7 in Ews-null cells restores PGC-1α.\",\n      \"method\": \"Ews knockout mice, ubiquitination assay, proteasome inhibitor rescue, Fbxw7 knockdown rescue, mitochondrial abundance/activity measurement, immunoblotting\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with complementation rescue, ubiquitination assay, FBXW7 KD rescue, and in vivo tissue analyses, multiple orthogonal methods\",\n      \"pmids\": [\"25918410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"EWSR1 suppresses R-loops and promotes homologous recombination in the transcriptional response to DNA damage; in Ewing sarcoma, EWS-FLI1 increases transcription causing R-loop accumulation and replication stress, and impairs BRCA1-mediated homologous recombination by enriching BRCA1 interactions with the elongating transcription machinery.\",\n      \"method\": \"R-loop immunofluorescence (S9.6 antibody), BRCA1 Co-IP with transcription machinery components, EWSR1 knockdown/rescue, DNA damage assays, replication stress assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal mechanistic assays in a high-profile study, loss-of-function with defined molecular phenotypes, published in Nature\",\n      \"pmids\": [\"29513652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"EWS-FLI1 modulates ARID1A pre-mRNA splicing to preferentially produce the ARID1A-L isoform; ARID1A-L directly interacts with EWS-FLI1 protein; ARID1A-L promotes Ewing sarcoma growth and reciprocally stabilizes EWS-FLI1 protein, forming a feed-forward oncogenic loop.\",\n      \"method\": \"Co-immunoprecipitation (EWS-FLI1 / ARID1A-L), RNA-seq for isoform analysis, shRNA knockdown, rescue experiments, protein stability assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with splicing and functional data, single lab\",\n      \"pmids\": [\"31392992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TRIM8 is an E3 ubiquitin ligase that ubiquitinates and degrades EWS-FLI1; TRIM8 knockout leads to increased EWS-FLI1 protein levels that is not tolerated by Ewing sarcoma cells; EWS-FLI1 acts as a neomorphic substrate for TRIM8, defining a selective dependency.\",\n      \"method\": \"CRISPR-Cas9 screen, ubiquitination assay, TRIM8 KO/rescue, protein level analysis, selective dependency validation across >700 cancer cell lines\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — CRISPR screen plus biochemical ubiquitination assay and mechanistic rescue with cross-cancer-line selectivity validation\",\n      \"pmids\": [\"34329586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SPOP E3 ubiquitin ligase and OTUD7A deubiquitinase control EWS-FLI1 protein stability: casein kinase 1-mediated phosphorylation of the VTSSS degron in the FLI1 domain enhances SPOP-mediated degradation; OTUD7A deubiquitinates and stabilizes EWS-FLI1; depletion of OTUD7A reduces EWS-FLI1 levels and impedes tumor growth in vitro and in vivo.\",\n      \"method\": \"siRNA/shRNA depletion, ubiquitination assays, Co-IP, phosphorylation assays, xenograft mouse models, AI-based drug screening\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical assays with in vivo validation, single lab\",\n      \"pmids\": [\"34060252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"USP19 deubiquitinase binds to the N-terminal EWS region of EWS-FLI1 and stabilizes the fusion protein; depletion of USP19 reduces EWS-FLI1 protein levels, decreases cell growth, and delays tumor growth in vivo; stabilization is specific for the fusion protein (not EWSR1 or FLI1 alone).\",\n      \"method\": \"siRNA screening, Co-IP, ubiquitination assays, stable shRNA depletion, xenograft tumor assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA screen with biochemical follow-up and in vivo validation, single lab\",\n      \"pmids\": [\"30700749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"EWS-FLI1 is incorporated into a protein granule/assembly in cells via its low-complexity (LC) domain; the LC domain is required for EWS-FLI1 to form these assemblies and interact with its broad network of protein partners including RNA Pol II; EWSR1 knockdown affects a larger than expected set of transcripts, including many EWS-FLI1-regulated genes.\",\n      \"method\": \"Cross-linking-based protein assembly assay, siRNA-mediated knockdown, RNA-seq, domain deletion analysis\",\n      \"journal\": \"RNA\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cross-linking assembly assay with domain deletion and transcriptomic validation, single lab\",\n      \"pmids\": [\"34035145\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"EWSR1-ATF1 displays distinct DNA binding that requires the EWSR1 domain and promotes ATF1 retargeting to new distal chromatin sites, activating a 3D connectivity network controlling oncogenic and differentiation programs in Clear Cell Sarcoma; EWSR1-ATF1 depletion reconfigures 3D connectivity and promotes neural crest developmental programs.\",\n      \"method\": \"ChIP-seq, Hi-C/3D chromatin conformation capture, ATAC-seq, EWSR1-ATF1 depletion, CUT&RUN\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple epigenomic methods with depletion experiments, single lab\",\n      \"pmids\": [\"35477713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"EWSR1 maintains centromere identity by interacting with CENP-A through its SYGQ2 prion-like domain region; EWSR1 binds R-loops through its RNA-recognition motif in vitro; both the SYGQ2 domain and RNA-recognition motif are required for EWSR1 to maintain CENP-A at the centromere in interphase cells.\",\n      \"method\": \"Co-immunoprecipitation (CENP-A–EWSR1), CENP-A ChIP after EWSR1 depletion, in vitro R-loop binding assay, domain deletion/mutation analysis, immunofluorescence\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with domain mutants and functional CENP-A ChIP, single lab, in vitro R-loop binding assay\",\n      \"pmids\": [\"37243594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The intrinsically disordered low-complexity domain of EWS (EWSLCD) undergoes phase separation/condensate formation driven by tyrosine residues; higher density and proximity of tyrosines amplify condensate formation; MD simulations revealed tyrosine-rich termini adopt compact conformations with unique intramolecular and intermolecular contact networks.\",\n      \"method\": \"Paramagnetic relaxation enhancement NMR, microscopy (phase separation), all-atom molecular dynamics simulations, mutational analysis of tyrosine residues\",\n      \"journal\": \"Journal of the American Chemical Society\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR, MD simulations, and microscopy with mutational analysis, single lab, rigorous biophysical study\",\n      \"pmids\": [\"38492239\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"EWSR1 encodes a multifunctional RNA/DNA-binding protein whose N-terminal low-complexity/prion-like domain (which undergoes phase separation driven by tyrosine residues) serves as a potent transcriptional activation domain when fused to ETS or other transcription factor DNA-binding domains in oncogenic translocations; wild-type EWSR1 regulates transcription (binding RNA Pol II and chromatin), pre-mRNA splicing (interacting with SF1, U1C, DDX5, hnRNP K, PRPF6), suppresses DNA damage-induced R-loops to promote homologous recombination, maintains centromere identity by binding CENP-A via its SYGQ2 domain and centromeric R-loops via its RNA-recognition motif, recruits Aurora B kinase to the midzone through its RGG3 domain to enable cytokinesis, controls PGC-1α protein stability (via FBXW7 ubiquitin ligase) to maintain mitochondrial homeostasis, regulates miRNA biogenesis by modulating Drosha expression, interacts with lamin A/C to support nuclear architecture and senescence suppression, and is essential for B-cell development and meiosis in vivo; EWSR1 protein stability is regulated by the E3 ligases TRIM8 and SPOP (enhanced by CK1 phosphorylation of a degron) and countered by the deubiquitinases OTUD7A and USP19, while arginine methylation controls its subcellular localization and cell-surface exposure.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"EWSR1 is a multifunctional RNA/DNA-binding protein whose N-terminal low-complexity, prion-like domain undergoes tyrosine-driven phase separation and mediates homo- and heterotypic protein assemblies, while its C-terminal RNA-binding region directs RNA-dependent self-association [#5, #32]. In its wild-type role, EWSR1 supports genome integrity and mitotic fidelity: it suppresses DNA damage-induced R-loops to promote BRCA1-mediated homologous recombination [#24], maintains centromere identity by binding CENP-A through its SYGQ2 prion-like region and centromeric R-loops via its RNA-recognition motif [#31], and recruits Aurora B to the anaphase midzone through the R565 residue of its RGG3 domain to enable faithful division [#20], consistent with the spindle and apoptotic defects seen upon its loss [#10]. EWSR1 acts in transcription and pre-mRNA splicing, cooperating with REST to repress neuronal genes [#16] and controls miRNA biogenesis by modulating Drosha to govern target genes during development [#15]. It also sustains mitochondrial homeostasis by protecting PGC-1\\u03b1 from FBXW7-dependent proteasomal degradation [#23], interacts with lamin A/C, and is required in vivo for B-cell development, meiosis, and suppression of premature senescence [#9, #13]. The protein is heavily asymmetrically dimethylated on arginines within its RGG motifs, a modification controlling its abundance, nuclear/cell-surface localization [#4, #6]. EWSR1 is recurrently the 5' partner in oncogenic fusions (EWS-FLI1, EWS-ATF1, EWSR1-NR4A3, EWS-WT1) where its intrinsically disordered N-terminal domain functions as a phase-separating transactivation module appended to a heterologous DNA-binding domain, reprogramming chromatin and 3D genome architecture and corrupting splicing [#7, #17, #18, #29, #30].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Established that in the EWS-FLI1 fusion the heterologous ETS domain, not the EWS portion, dictates sequence-specific DNA binding, localizing the contribution of EWS to transactivation rather than recognition.\",\n      \"evidence\": \"in vitro binding-site selection and truncation DNA-binding assays with epitope-tagged protein\",\n      \"pmids\": [\"7517940\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not address the function of wild-type EWSR1\", \"Did not test fusion activity in chromatin context\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Defined the EWS N-terminal domain as a transcriptional regulatory module that modulates the activity of the fused FLI1 domain, framing the fusion as a chimeric transcription factor.\",\n      \"evidence\": \"transcriptional reporter assays with deletion constructs in transfected cells\",\n      \"pmids\": [\"7503813\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of activation not biochemically defined\", \"Wild-type EWSR1 transcriptional role not addressed\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Connected EWSR1 to the splicing machinery and showed the fusion perturbs splice-site selection, opening a non-transcriptional axis of EWSR1 function.\",\n      \"evidence\": \"in vivo E1A splicing assay, mutational analysis and interaction assays with SF1/U1C\",\n      \"pmids\": [\"11301318\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct RNA targets in vivo not mapped\", \"Splicing role of wild-type EWSR1 incompletely resolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Mapped extensive asymmetric arginine dimethylation across the RGG motifs and detected EWS at the cell surface, establishing a post-translational code and unexpected localization.\",\n      \"evidence\": \"cell-surface biotinylation, isoelectric focusing and tandem mass spectrometry site mapping\",\n      \"pmids\": [\"11278906\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Responsible methyltransferase not identified\", \"Functional consequence of each methylation site untested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed EWSR1 self-associates in an RNA-dependent manner via its C-terminal RNA-binding domain while the N-terminal domain mediates homo/heterotypic interactions, defining the basis for its higher-order assembly.\",\n      \"evidence\": \"FRET, mammalian two-hybrid, GST pull-down, Co-IP with RNaseA sensitivity\",\n      \"pmids\": [\"14534527\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of assemblies not determined\", \"Link to phase separation not yet drawn\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated that arginine methylation controls EWS abundance and partitioning between nucleus and cell surface, with mitogenic signals tuning surface exposure.\",\n      \"evidence\": \"methylation-inhibitor treatment, cell-surface biotinylation, mitogenic stimulation of T cells\",\n      \"pmids\": [\"12915128\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Pharmacological inhibition is not site-specific\", \"Mechanism linking methylation to localization unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Established that the fusion protein is intrinsically disordered yet retains DNA binding and transcriptional activity, anchoring the concept that EWSR1's disordered domain is functionally active without folding.\",\n      \"evidence\": \"recombinant protein purification, circular dichroism, fluorescence spectroscopy, in vitro DNA-binding/transcription assays\",\n      \"pmids\": [\"15491164\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Behavior of full-length protein in cells not addressed\", \"Condensate behavior not yet examined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified RNA helicase A as a direct cofactor that co-occupies fusion target promoters and amplifies oncogenic transcription and transformation.\",\n      \"evidence\": \"phage display, GST pull-down, ELISA, reciprocal Co-IP, ChIP, reporter and anchorage-independent growth assays\",\n      \"pmids\": [\"16740692\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether wild-type EWSR1 uses the same interaction surface untested\", \"Genome-wide co-occupancy not mapped\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined essential in vivo roles for EWSR1 in B-cell development, meiosis, and senescence suppression and identified lamin A/C as a partner, establishing physiological functions beyond cancer.\",\n      \"evidence\": \"Ews knockout mice, lymphocyte/meiosis analysis, MEF senescence and irradiation assays, Co-IP\",\n      \"pmids\": [\"17415412\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of meiotic and DNA-damage phenotypes not resolved\", \"Direct vs indirect lamin A/C effects unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed EWSR1 is required for mitotic spindle integrity across zebrafish and human cells, linking its loss to chromosomal instability and apoptosis.\",\n      \"evidence\": \"morpholino knockdown in zebrafish, siRNA in HeLa, mitotic spindle imaging\",\n      \"pmids\": [\"17912356\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism at the spindle not defined here\", \"Knockdown specificity not exhaustively controlled\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Established EWSR1 as a regulator of hematopoietic stem cell quiescence whose loss triggers p16-driven senescence.\",\n      \"evidence\": \"Ews knockout mice, HSPC flow cytometry, \\u03b2-galactosidase and p16INK4a assays\",\n      \"pmids\": [\"21030557\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular targets in HSCs not identified\", \"Relationship to senescence pathways in other tissues unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed EWSR1 controls miRNA biogenesis by restraining Drosha, defining a post-transcriptional output that shapes developmental gene expression.\",\n      \"evidence\": \"Ews-null MEFs, miRNA qPCR, Drosha knockdown rescue, target immunoblotting\",\n      \"pmids\": [\"24185621\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of Drosha regulation not resolved\", \"Direct vs indirect control of Drosha expression unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified a wild-type EWSR1\\u2013REST complex on chromatin that cooperatively silences neuronal genes and restrains transformation.\",\n      \"evidence\": \"Co-IP, ChIP-seq, RNA-seq after RNAi, transformation assays\",\n      \"pmids\": [\"24069508\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct DNA-binding role of EWSR1 within the complex unclear\", \"Single-lab ChIP-seq, no reciprocal validation\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Resolved two divergent gene-regulatory mechanisms of EWS-FLI1 \\u2014 de novo enhancer creation at GGAA microsatellites and inactivation of native ETS enhancers \\u2014 explaining its dual activation/repression output.\",\n      \"evidence\": \"ChIP-seq, ATAC/DNaseI-seq, chromatin conformation capture, knockdown/rescue, reporter assays\",\n      \"pmids\": [\"25453903\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Role of EWS phase separation in enhancer formation not addressed here\", \"Wild-type EWSR1 enhancer behavior not compared\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrated that EWSR1 fusions to other DNA-binding partners (WT1, ATF1) generate novel binding specificities and target programs, generalizing the chimeric-transactivator model across sarcomas.\",\n      \"evidence\": \"in vitro/in vivo binding assays, ChIP, mutagenesis, transgenic and inducible expression models\",\n      \"pmids\": [\"12923058\", \"24934812\", \"23281395\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the EWS domain alters partner specificity mechanistically not resolved\", \"Direct target sets incompletely catalogued\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Mapped EWSR1 recruitment of Aurora B to the midzone via the RGG3 R565 residue, providing a molecular basis for its role in cytokinesis and ploidy control.\",\n      \"evidence\": \"siRNA knockdown, midzone imaging, Co-IP, domain/point mutation and rescue\",\n      \"pmids\": [\"25483190\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether methylation of R565 regulates the interaction untested\", \"Reciprocal validation of Aurora B interaction limited\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined EWS-FLI1 as a splicing regulatory hub binding nascent RNA and spliceosomal factors, and showed RHA helicase inhibition by the fusion, with both reversible by YK-4-279.\",\n      \"evidence\": \"CLIP-seq, exon array/RNA-seq, Co-IP with DDX5/hnRNP K/PRPF6, in vitro helicase/ATPase assays, enantiomer-specific inhibition\",\n      \"pmids\": [\"25737553\", \"25564528\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Splicing role of wild-type EWSR1 not directly compared\", \"In vivo significance of altered isoforms incompletely tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Established that EWSR1 suppresses R-loops to enable homologous recombination, and that the fusion's transcriptional excess drives R-loop-associated replication stress and HR defects.\",\n      \"evidence\": \"S9.6 R-loop immunofluorescence, BRCA1 Co-IP with transcription machinery, knockdown/rescue, DNA damage and replication stress assays\",\n      \"pmids\": [\"29513652\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct RNA/DNA species bound by EWSR1 at R-loops not fully defined\", \"How EWSR1 dislodges BRCA1 from elongation machinery unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showed EWSR1 stabilizes PGC-1\\u03b1 by limiting FBXW7-mediated degradation, linking the protein to mitochondrial biogenesis in multiple tissues.\",\n      \"evidence\": \"Ews knockout mice, ubiquitination assay, proteasome and Fbxw7 knockdown rescue, mitochondrial measurements\",\n      \"pmids\": [\"25918410\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular step by which EWSR1 limits FBXW7 unknown\", \"Whether EWSR1 acts on PGC-1\\u03b1 transcription or protein directly not fully separated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified deubiquitinase- and ligase-based control of fusion protein abundance, establishing EWS-FLI1 stability as a druggable dependency.\",\n      \"evidence\": \"siRNA/CRISPR screens, Co-IP, ubiquitination and phosphorylation assays, xenografts (USP19, TRIM8, SPOP/OTUD7A)\",\n      \"pmids\": [\"30700749\", \"34329586\", \"34060252\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether these enzymes also regulate wild-type EWSR1 partly unresolved\", \"Interplay among the competing ligases/DUBs not integrated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Linked the low-complexity domain to formation of cellular protein assemblies required for the fusion's broad partner network including RNA Pol II, bridging biochemistry to gene regulation.\",\n      \"evidence\": \"cross-linking assembly assay, domain deletion, siRNA knockdown, RNA-seq\",\n      \"pmids\": [\"34035145\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether assemblies are bona fide phase-separated condensates not proven here\", \"Composition of assemblies not exhaustively defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined EWSR1 as a centromere identity factor acting through CENP-A binding via SYGQ2 and R-loop binding via its RRM, connecting its disordered and RNA-binding modules to chromosome segregation.\",\n      \"evidence\": \"Co-IP, CENP-A ChIP after depletion, in vitro R-loop binding, domain mutation analysis, immunofluorescence\",\n      \"pmids\": [\"37243594\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which EWSR1 retains CENP-A not resolved\", \"In vivo significance for chromosome segregation not fully tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Provided molecular detail that tyrosine residues drive phase separation of the EWS low-complexity domain, defining the sequence determinants of its condensate behavior.\",\n      \"evidence\": \"PRE-NMR, microscopy, all-atom MD simulations, tyrosine mutational analysis\",\n      \"pmids\": [\"38492239\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cellular function of these condensates not directly tested\", \"Link to transactivation strength of full-length protein not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How arginine methylation, tyrosine-driven phase separation, and the competing ubiquitination/deubiquitination network are integrated to coordinate EWSR1's transcription, splicing, centromere, R-loop, and mitochondrial functions remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking modifications to specific functional outputs\", \"Substrate/target specificity of wild-type vs fusion incompletely separated\", \"Structural basis of higher-order assembly in cells undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [5, 21, 22, 31]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 18]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 16, 17]},\n      {\"term_id\": \"GO:0045182\", \"supporting_discovery_ids\": [15, 21]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [20, 23]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 16, 17]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4, 6]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [31]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [10, 20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [16, 17]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [15, 21]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [24]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [10, 20, 31]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [17, 26]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"FLI1\", \"DHX9\", \"DDX5\", \"HNRNPK\", \"PRPF6\", \"REST\", \"AURKB\", \"LMNA\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":6,"faith_pct":83.33333333333333}}